STOCK Map3k7tm1.1Gkl/Flmg

Status

Available to order

EMMA IDEM:08404
Citation informationRRID:IMSR_EM:08404 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameSTOCK Map3k7tm1.1Gkl/Flmg
Alternative nameTAK1FL/FL [B6-Map3k7tm1.1Gkl/Flmg]
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolMap3k7tm1.1Gkl
Gene/Transgene symbolMap3k7

Information from provider

ProviderGeorge Kollias
Provider affiliationBSRC Al. Fleming
Genetic informationA targeting vector was constructed in which a 0.6 kb fragment of Map3k7 containing exon 2 was flanked by loxP sites. The targeting vector also contained an FRT-neo-FRT selection cassette next to the first loxP site and before exon 2.
Phenotypic informationHomozygous:
No overt phenotype.

Heterozygous:
No overt phenotype
References
  • Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia.;Eftychi Christina, Karagianni Niki, Alexiou Maria, Apostolaki Maria, Kollias George, ;2012;PloS one;7;e31550; 22348103
  • Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.;Nikolaou Kostas, Tsagaratou Ageliki, Eftychi Christina, Kollias George, Mosialos George, Talianidis Iannis, ;2012;Cancer cell;21;738-50; 22698400
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreB.S.R.C. Alexander Fleming, Vari, Greece
Animals used for archivinghomozygous C57BL/6J males

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • preweaning lethality, complete penetrance / IMPC
  • abnormal lens morphology / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • embryonic lethality prior to tooth bud stage / IMPC
MGI phenotypes (gene matching)
  • abnormal vascular development / MGI
  • abnormal heart morphology / MGI
  • abnormal vascular regression / MGI
  • microcephaly / MGI
  • short tail / MGI
  • open neural tube / MGI
  • wavy neural tube / MGI
  • abnormal blood vessel morphology / MGI
  • decreased embryo size / MGI
  • edema / MGI
  • pericardial edema / MGI
  • hemorrhage / MGI
  • small heart / MGI
  • abnormal myocardial trabeculae morphology / MGI
  • abnormal pharyngeal arch artery morphology / MGI
  • abnormal vitelline vasculature morphology / MGI
  • thin myocardium compact layer / MGI
  • abnormal vitelline vascular remodeling / MGI
  • abnormal dorsal aorta morphology / MGI
  • abnormal vascular smooth muscle morphology / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • absent fibroblast proliferation / MGI
  • embryo tissue necrosis / MGI

Literature references

  • Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia.;Eftychi Christina, Karagianni Niki, Alexiou Maria, Apostolaki Maria, Kollias George, ;2012;PloS one;7;e31550; 22348103
  • Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.;Nikolaou Kostas, Tsagaratou Ageliki, Eftychi Christina, Kollias George, Mosialos George, Talianidis Iannis, ;2012;Cancer cell;21;738-50; 22698400
  • Ubiquitin-specific peptidase 18 negatively regulates and inhibits lipopolysaccharide-induced sepsis by targeting transforming growth factor-β-activated kinase 1 activity.;Hu Bin, Ge Chunhua, Zhu Chunqing, ;2021;International immunology;33;461-468; 34423815

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).